Sequencing science
Genetic clarity, built for families.
GeneSprout pairs whole-exome and whole-genome sequencing with a curated, clinician led condition list — so you get answers that are actionable.
- CLIA & CAP certified lab
- ACMG variant classification
- Results in 4 weeks or less
- Ongoing monitoring of latest science
Clinical Grade Screening
The test you choose changes everything.
Most consumer tests screen a limited panel of genes. Broader tests can overwhelm you with uncertain or inconclusive findings that sound alarming but have no clear action. GeneSprout is different.
SNP microarray testing
Pre-selected SNPs tests can have high false-positve rate
Whole-exome & whole-genome
The most comprehensive sequencing available today
High VUS burden
Many uncertain variants create anxiety without actionability
Curated condition list
Only actionable, clinically meaningful findings are reported
No post-result support
You receive a PDF and navigate the rest alone
Health navigation included
When a risk is identified, a specialist guides your next steps
Consumer-grade labs
Variable CLIA status; not always pediatric-focused
CAP/CLIA-certified US lab
Clinical-grade accuracy with pediatric-relevant focus
How it works
A test and a partner for the whole journey.
GeneSprout isn't a transaction. It's a process designed to be clear, supported, and useful whether results are negative or flag a risk.
Order your test
Choose your coverage level; kit arrives in 3–5 days
Sample collection
Simple at-home cheek swab collection; no clinic visit
Lab sequencing
Whole-exome or whole-genome analysis at CAP/CLIA lab
Your report
Plain-language and actionable; arrives in 4 weeks.
Risk identified?
Health navigation specialist contacts you
Included with every positive screen
Health Navigation
A positive screening result raises questions. Our health navigators are pediatricians, supporting your family to understand findings, explore next steps, and help guide you to further resources if needed. Licensed genetic counselors are available to provide more information on genetic risk. You're never interpreting a report alone.
What we screen for
Conditions where early knowledge changes outcomes.
We focus on conditions where genetic information is meaningful actionable — where knowing early leads to better monitoring, earlier treatment, targeted support, or more informed care decisions.
Neuro-developmental
Autism spectrum disorder, intellectual disability, and developmental delay have a genetic cause in up to 40% of cases. A result can suggest targeted interventions.
Epilepsy & Seizure
Over 30% of childhood epilepsies are genetic in origin. The specific genetic variant often determines which medications work, which to avoid, and what additional surveillance may be needed.
Sudden Cardiac Arrest
Hypertrophic cardiomyopathy, Long QT syndrome, and arrhythmogenic cardiomyopathy can be present at birth with no outward signs. Death can be the first symptom. Early identification allows proactive monitoring and prevention.
Metabolic Disorders
Many metabolic conditions are manageable when identified early. Left undetected, they can cause serious, irreversible harm during childhood development.
Medication Response
Your child's genes affect how they process common medications. For example, when receiving certain anesthetic medications, some children are at risk for malignant hyperthermia where muscles go into overdrive, generating too much heat, using up oxygen rapidly, and releasing harmful substances into the blood, which can be life-threatening.
Rare Disease Screening
We screen for hundreds of individually rare but collectively common conditions — many of which now have disease-modifying therapies available when identified early.
Two testing options
Whole Exome vs. Whole Genome Sequencing.
Both tests use a simple and painless cheek swab. The difference is in how much of your child's DNA is examined.
Whole Exome Sequencing (WES)
Examines the protein-coding regions of your child's DNA — the approximately 2% of the genome responsible for most known genetic conditions. A comprehensive, clinically validated approach that covers the vast majority of actionable findings.
Whole Genome Sequencing (WGS)
Examines the entirety of your child's DNA — including regions outside the protein-coding sequences. The most complete picture available, and the approach most likely to identify rare or newly discovered variants.
Resources
Go deeper on genetics & guidance.
Education
Genetics 101
What is sequencing? What does a variant mean? Plain-language guides for families new to genetic testing.
Stories
Real GeneSprout families
How early identification changed care plans — and the lives of families like yours.
Navigation
Condition navigation
What happens when a risk is found? Meet the team and process that walks with you.
Condition explorer
Browse all conditions
Search the full list of conditions GeneSprout screens for
Your child's genetic data belongs to your family — not to us. We never sell, share, or use it for research without your explicit consent.
Our privacy commitment →